PL1858917T3 - Szczepionka przeciw wirusowi ospy wietrznej i półpaśca - Google Patents
Szczepionka przeciw wirusowi ospy wietrznej i półpaścaInfo
- Publication number
- PL1858917T3 PL1858917T3 PL06707446T PL06707446T PL1858917T3 PL 1858917 T3 PL1858917 T3 PL 1858917T3 PL 06707446 T PL06707446 T PL 06707446T PL 06707446 T PL06707446 T PL 06707446T PL 1858917 T3 PL1858917 T3 PL 1858917T3
- Authority
- PL
- Poland
- Prior art keywords
- virus vaccine
- zoster virus
- varicella zoster
- varicella
- vaccine
- Prior art date
Links
- 229940124863 Varicella-zoster virus vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0504436.7A GB0504436D0 (en) | 2005-03-03 | 2005-03-03 | Vaccine |
| EP20060707446 EP1858917B8 (en) | 2005-03-03 | 2006-03-01 | Varicella zoster virus vaccine |
| PCT/EP2006/002070 WO2006094756A2 (en) | 2005-03-03 | 2006-03-01 | Varicella zoster virus vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1858917T3 true PL1858917T3 (pl) | 2015-05-29 |
Family
ID=34430592
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10188215T PL2301955T3 (pl) | 2005-03-03 | 2006-03-01 | Szczepionka przeciw wirusowi ospy wietrznej i półpaśca |
| PL10188214T PL2281830T3 (pl) | 2005-03-03 | 2006-03-01 | Szczepionka przeciw wirusowi ospy wietrznej i półpaśca |
| PL06707446T PL1858917T3 (pl) | 2005-03-03 | 2006-03-01 | Szczepionka przeciw wirusowi ospy wietrznej i półpaśca |
| PL10188256T PL2281831T3 (pl) | 2005-03-03 | 2006-03-01 | Szczepionka przeciw wirusowi ospy wietrznej i półpaśca |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10188215T PL2301955T3 (pl) | 2005-03-03 | 2006-03-01 | Szczepionka przeciw wirusowi ospy wietrznej i półpaśca |
| PL10188214T PL2281830T3 (pl) | 2005-03-03 | 2006-03-01 | Szczepionka przeciw wirusowi ospy wietrznej i półpaśca |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10188256T PL2281831T3 (pl) | 2005-03-03 | 2006-03-01 | Szczepionka przeciw wirusowi ospy wietrznej i półpaśca |
Country Status (35)
| Country | Link |
|---|---|
| US (3) | US20080171079A1 (lt) |
| EP (4) | EP2281830B1 (lt) |
| JP (2) | JP5420842B2 (lt) |
| KR (2) | KR20140006115A (lt) |
| CN (2) | CN103028113B (lt) |
| AR (2) | AR052498A1 (lt) |
| AU (1) | AU2006222225B2 (lt) |
| BR (1) | BRPI0607840B1 (lt) |
| CA (2) | CA2600905C (lt) |
| CY (5) | CY1116108T1 (lt) |
| DK (4) | DK2281830T3 (lt) |
| EA (1) | EA011884B1 (lt) |
| ES (4) | ES2618037T3 (lt) |
| GB (1) | GB0504436D0 (lt) |
| HK (1) | HK1111427A1 (lt) |
| HR (4) | HRP20150142T1 (lt) |
| HU (4) | HUE038467T2 (lt) |
| IL (1) | IL185442A (lt) |
| LT (4) | LT2281831T (lt) |
| LU (1) | LUC00087I2 (lt) |
| MA (1) | MA29714B1 (lt) |
| MX (2) | MX346865B (lt) |
| MY (1) | MY148464A (lt) |
| NL (1) | NL300951I2 (lt) |
| NO (1) | NO341841B1 (lt) |
| NZ (1) | NZ561075A (lt) |
| PE (2) | PE20061287A1 (lt) |
| PL (4) | PL2301955T3 (lt) |
| PT (4) | PT2281830T (lt) |
| SI (4) | SI2281830T1 (lt) |
| TR (2) | TR201809393T4 (lt) |
| TW (1) | TWI403517B (lt) |
| UA (1) | UA94900C2 (lt) |
| WO (1) | WO2006094756A2 (lt) |
| ZA (1) | ZA200707144B (lt) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0504436D0 (en) * | 2005-03-03 | 2005-04-06 | Glaxosmithkline Biolog Sa | Vaccine |
| TWI457133B (zh) * | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| US20100330122A1 (en) * | 2007-07-19 | 2010-12-30 | Gale Smith | VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES (VLPs) AND ANTIGENS |
| FR2952825B1 (fr) | 2009-11-24 | 2012-05-25 | Goaster Jacqueline Le | Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2 |
| BR112013000244A2 (pt) | 2010-07-06 | 2016-05-17 | Novartis Ag | lipossomas com lipídeos apresentando pka vantajoso para administração de rna |
| ES2646669T3 (es) | 2010-07-06 | 2017-12-14 | Glaxosmithkline Biologicals Sa | Procedimientos de aumento de una respuesta inmunitaria mediante el suministro de ARN |
| DK2591114T3 (en) | 2010-07-06 | 2016-08-29 | Glaxosmithkline Biologicals Sa | Immunization of large mammals with low doses of RNA |
| UA112970C2 (uk) * | 2010-08-05 | 2016-11-25 | Мерк Шарп Енд Доме Корп. | Інактивований вірус вітряної віспи, спосіб його одержання і застосування |
| DK4066857T3 (da) | 2010-08-31 | 2023-02-20 | Glaxosmithkline Biologicals Sa | Pegylerede liposomer til afgivelse af immunogen-kodende RNA |
| CA2814386C (en) | 2010-10-11 | 2019-08-20 | Novartis Ag | Antigen delivery platforms |
| CA2840989A1 (en) | 2011-07-06 | 2013-01-10 | Novartis Ag | Immunogenic combination compositions and uses thereof |
| US9849066B2 (en) | 2013-04-24 | 2017-12-26 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| WO2015050181A1 (ja) * | 2013-10-03 | 2015-04-09 | 日東電工株式会社 | 注射ワクチン組成物 |
| JP6499420B2 (ja) * | 2014-11-13 | 2019-04-10 | 公益財団法人ヒューマンサイエンス振興財団 | ワクチン及び感染防御キット |
| BR112017012647A2 (pt) * | 2014-12-18 | 2018-01-09 | Glaxosmithkline Biologicals Sa | composição imunogênica, método para proteção contra ou prevenção de herpes zoster (hz) e/ou neuralgia pós-herpética, e, método para proteção contra, prevenção ou redução da incidência de herpes zoster e/ou neuralgia pós-herpética. |
| BE1022523B1 (fr) * | 2014-12-18 | 2016-05-20 | Glaxosmithkline Biologicals Sa | Vaccination |
| DE20164728T1 (de) | 2015-10-22 | 2021-09-30 | Modernatx, Inc. | Impfstoffe gegen atemwegsvirus |
| AU2016342371B2 (en) * | 2015-10-22 | 2023-05-11 | Modernatx, Inc. | Nucleic acid vaccines for varicella zoster virus (VZV) |
| JP6900385B2 (ja) | 2015-11-06 | 2021-07-07 | アジュバンス・テクノロジーズ・インコーポレーテッド | トリテルペンサポニン類似物 |
| WO2018089851A2 (en) | 2016-11-11 | 2018-05-17 | Modernatx, Inc. | Influenza vaccine |
| US10874734B2 (en) | 2016-11-25 | 2020-12-29 | Mogam Institute For Biomedical Research | Varicella zoster virus vaccine |
| WO2018097642A1 (ko) * | 2016-11-25 | 2018-05-31 | 재단법인 목암생명과학연구소 | 바리셀라 조스터 바이러스 백신 |
| CN107022559A (zh) * | 2016-12-08 | 2017-08-08 | 长春祈健生物制品有限公司 | 一种水痘‑带状疱疹病毒糖蛋白e胞外区蛋白的制备方法 |
| GB201621686D0 (en) | 2016-12-20 | 2017-02-01 | Glaxosmithkline Biologicals Sa | Novel methods for inducing an immune response |
| BR112019013284A2 (pt) * | 2016-12-26 | 2019-12-17 | Mogam Institute For Biomedical Research | composição de vacina para herpes zóster |
| CN108727503A (zh) * | 2017-04-18 | 2018-11-02 | 武汉博沃生物科技有限公司 | VZV重组gE-鞭毛素融合蛋白及其制备方法和应用 |
| SG11201909584QA (en) * | 2017-04-25 | 2019-11-28 | Adjuvance Technologies Inc | Triterpene saponin analogues |
| CN110730666A (zh) * | 2017-04-25 | 2020-01-24 | 佐剂技术公司 | 三萜皂苷类似物 |
| US20210187098A1 (en) | 2017-04-28 | 2021-06-24 | Glaxosmithkline Biologicals Sa | Vaccination |
| GB201707700D0 (en) | 2017-05-12 | 2017-06-28 | Glaxosmithkline Biologicals Sa | Dried composition |
| IE87439B1 (en) | 2017-05-30 | 2023-10-11 | Glaxosmithkline Biologicals Sa | Novel methods for manufacturing an adjuvant |
| EP3697802A4 (en) | 2017-10-16 | 2021-11-24 | Adjuvance Technologies, Inc. | TRITERPENIC SAPONIN ANALOGUES |
| CA3083078A1 (en) | 2017-12-01 | 2019-06-06 | Glaxosmithkline Biologicals Sa | Saponin purification |
| CN108315344A (zh) * | 2018-02-14 | 2018-07-24 | 武汉博沃生物科技有限公司 | Vzv糖蛋白e基因表达载体及其重组酵母菌株与应用 |
| KR102337922B1 (ko) | 2018-04-19 | 2021-12-09 | 가천대학교 산학협력단 | 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물 |
| KR20190121956A (ko) | 2018-04-19 | 2019-10-29 | 가천대학교 산학협력단 | 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물 |
| CN112189017A (zh) * | 2018-05-23 | 2021-01-05 | 财团法人牧岩生命科学研究所 | 水痘带状疱疹病毒的抗原变体及其用途 |
| EP3833382A1 (en) | 2018-08-07 | 2021-06-16 | GlaxoSmithKline Biologicals S.A. | Processes and vaccines |
| CN108992667A (zh) * | 2018-08-09 | 2018-12-14 | 安徽智飞龙科马生物制药有限公司 | 一种带状疱疹疫苗及其制备方法、应用 |
| KR102270048B1 (ko) | 2020-07-10 | 2021-06-28 | 주식회사 녹십자 | 바리셀라 조스터 바이러스 표면 단백질 항원의 생산 방법 |
| AU2019349036A1 (en) * | 2018-09-27 | 2021-06-03 | Bravovax Co., Ltd | Immune composition, preparation method therefor, and application thereof |
| EP3886901A1 (en) | 2018-11-29 | 2021-10-06 | GlaxoSmithKline Biologicals S.A. | Methods for manufacturing an adjuvant |
| CN109602901B (zh) * | 2019-01-08 | 2022-05-27 | 成都迈科康生物科技有限公司 | 一种带状疱疹病毒疫苗及其制备方法和应用 |
| US20220235095A1 (en) | 2019-06-05 | 2022-07-28 | Glaxosmithkline Biologicals Sa | Saponin purification |
| CN112142828B (zh) * | 2019-06-28 | 2022-02-01 | 怡道生物科技(苏州)有限公司 | 一种gE基因及表达该基因的载体 |
| JP2023506441A (ja) * | 2019-12-13 | 2023-02-16 | 遠大賽威信生命科学（南京）有限公司 | 医薬組成物及びその用途 |
| JP2023516629A (ja) * | 2020-02-28 | 2023-04-20 | セルトリオン， インク． | 水痘帯状疱疹ウイルス融合タンパク質およびこれを含む免疫原性組成物 |
| CA3188708A1 (en) | 2020-08-07 | 2022-02-10 | Access To Advanced Health Institute | Purified saponins and chromatographic process for purification of same |
| WO2022055176A1 (ko) * | 2020-09-11 | 2022-03-17 | 주식회사 유바이오로직스 | 수두 또는 대상포진 백신 조성물 및 이를 이용하는 방법 |
| RU2750818C1 (ru) * | 2020-11-19 | 2021-07-05 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова | Вирусный штамм для получения аттенуированной живой культуральной вакцины для профилактики и лечения опоясывающего герпеса для взрослого населения |
| WO2023056912A1 (en) * | 2021-10-08 | 2023-04-13 | Suzhou Abogen Biosciences Co., Ltd. | Nucleic acid vaccines for vzv |
| WO2023064612A2 (en) | 2021-10-15 | 2023-04-20 | BioNTech SE | Pharmaceutical compositions for delivery of viral antigens and related methods |
| AU2022397292A1 (en) | 2021-11-24 | 2024-05-30 | Flagship Pioneering Innovations Vi, Llc | Varicella-zoster virus immunogen compositions and their uses |
| CN116350770A (zh) * | 2021-12-28 | 2023-06-30 | 成都迈科康生物科技有限公司 | 一种带状疱疹疫苗制剂及其制备方法 |
| WO2024017827A1 (en) | 2022-07-19 | 2024-01-25 | Glaxosmithkline Biologicals Sa | Continuous process for vaccine production |
| CN116655748A (zh) * | 2023-02-28 | 2023-08-29 | 易慧生物技术(上海)有限公司 | 一种截短型水痘-带状疱疹病毒gE蛋白及其应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5341202B2 (lt) | 1974-03-12 | 1978-11-01 | ||
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| US4769239A (en) | 1984-08-21 | 1988-09-06 | Merck & Co., Inc. | Vaccine against varicella-zoster virus |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| ES2071770T3 (es) | 1989-06-27 | 1995-07-01 | Smithkline Beecham Biolog | Nuevos compuestos. |
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| ZA929870B (en) | 1991-12-23 | 1993-08-18 | Duphar Int Res | Adjuvants |
| KR100278157B1 (ko) | 1992-06-25 | 2001-01-15 | 장 스테판느 | 보조약을 함유하는 백신 조성물 |
| ES2165367T5 (es) | 1992-07-17 | 2009-08-05 | MERCK & CO., INC. | Procedimiento para prevenir el herpes zoster o para aliviar la neuralgia post-herpetica relacionada con la varicela. |
| PT812593E (pt) | 1993-03-23 | 2002-01-30 | Smithkline Beecham Biolog | Vacinas contendo monofosforil-lipido a 3-o-desacilado na sua composicao |
| US5976552A (en) * | 1995-04-28 | 1999-11-02 | Protein Sciences Corporation | Virus vaccines |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| ATE509102T1 (de) | 1994-07-15 | 2011-05-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| ATE279517T1 (de) * | 1995-03-23 | 2004-10-15 | Immunex Corp | Il-17 receptor |
| UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US6846489B1 (en) | 1995-04-25 | 2005-01-25 | Smithkline Beecham Biologicals S.A. | Vaccines containing a saponin and a sterol |
| KR0177323B1 (ko) * | 1996-02-16 | 1999-04-01 | 성재갑 | 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법 |
| BR9811262A (pt) | 1997-04-01 | 2000-10-17 | Ribi Immunochem Research Inc | Composições auxiliares imunológicas aquosas de lipìdio de monofosforila a. |
| ES2201551T3 (es) | 1997-09-05 | 2004-03-16 | Glaxosmithkline Biologicals S.A. | Emulsiones de aceite en agua que contienen saponinas. |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| GB9901254D0 (en) * | 1999-01-20 | 1999-03-10 | Smithkline Beecham Biolog | Vaccines |
| CZ302449B6 (cs) | 2000-10-18 | 2011-05-25 | Glaxosmithkline Biologicals S. A. | Vakcinacní prostredky |
| GB0504436D0 (en) * | 2005-03-03 | 2005-04-06 | Glaxosmithkline Biolog Sa | Vaccine |
-
2005
- 2005-03-03 GB GBGB0504436.7A patent/GB0504436D0/en not_active Ceased
-
2006
- 2006-03-01 MY MYPI20060879A patent/MY148464A/en unknown
- 2006-03-01 AR ARP060100773A patent/AR052498A1/es not_active Application Discontinuation
- 2006-03-01 CA CA2600905A patent/CA2600905C/en active Active
- 2006-03-01 PT PT101882140T patent/PT2281830T/pt unknown
- 2006-03-01 PT PT67074468T patent/PT1858917E/pt unknown
- 2006-03-01 CN CN201210552767.6A patent/CN103028113B/zh active Active
- 2006-03-01 LT LTEP10188256.1T patent/LT2281831T/lt unknown
- 2006-03-01 HU HUE10188256A patent/HUE038467T2/hu unknown
- 2006-03-01 TW TW095106863A patent/TWI403517B/zh not_active IP Right Cessation
- 2006-03-01 MX MX2012004471A patent/MX346865B/es unknown
- 2006-03-01 WO PCT/EP2006/002070 patent/WO2006094756A2/en active Application Filing
- 2006-03-01 PT PT101882561T patent/PT2281831T/pt unknown
- 2006-03-01 TR TR2018/09393T patent/TR201809393T4/tr unknown
- 2006-03-01 LT LTEP10188215.7T patent/LT2301955T/lt unknown
- 2006-03-01 SI SI200632138A patent/SI2281830T1/sl unknown
- 2006-03-01 SI SI200631890T patent/SI1858917T1/sl unknown
- 2006-03-01 MX MX2007010626A patent/MX2007010626A/es active IP Right Grant
- 2006-03-01 UA UAA200709537A patent/UA94900C2/uk unknown
- 2006-03-01 ES ES10188214.0T patent/ES2618037T3/es active Active
- 2006-03-01 EP EP10188214.0A patent/EP2281830B1/en active Active
- 2006-03-01 NZ NZ561075A patent/NZ561075A/en not_active IP Right Cessation
- 2006-03-01 EP EP10188215.7A patent/EP2301955B1/en active Active
- 2006-03-01 PL PL10188215T patent/PL2301955T3/pl unknown
- 2006-03-01 ES ES06707446.8T patent/ES2532803T3/es active Active
- 2006-03-01 EP EP10188256.1A patent/EP2281831B1/en active Active
- 2006-03-01 ES ES10188256.1T patent/ES2675055T3/es active Active
- 2006-03-01 LT LTEP10188214.0T patent/LT2281830T/lt unknown
- 2006-03-01 JP JP2007557447A patent/JP5420842B2/ja active Active
- 2006-03-01 HU HUE10188214A patent/HUE032544T2/en unknown
- 2006-03-01 HU HUE10188215A patent/HUE038468T2/hu unknown
- 2006-03-01 DK DK10188214.0T patent/DK2281830T3/en active
- 2006-03-01 PL PL10188214T patent/PL2281830T3/pl unknown
- 2006-03-01 CN CN2006800152455A patent/CN101189254B/zh active Active
- 2006-03-01 PL PL06707446T patent/PL1858917T3/pl unknown
- 2006-03-01 DK DK10188215.7T patent/DK2301955T3/en active
- 2006-03-01 TR TR2018/09397T patent/TR201809397T4/tr unknown
- 2006-03-01 DK DK10188256.1T patent/DK2281831T3/en active
- 2006-03-01 ES ES10188215.7T patent/ES2675054T3/es active Active
- 2006-03-01 KR KR1020137034242A patent/KR20140006115A/ko not_active Application Discontinuation
- 2006-03-01 PE PE2006000237A patent/PE20061287A1/es not_active Application Discontinuation
- 2006-03-01 PT PT101882157T patent/PT2301955T/pt unknown
- 2006-03-01 SI SI200632264T patent/SI2301955T1/en unknown
- 2006-03-01 CA CA2882255A patent/CA2882255C/en active Active
- 2006-03-01 EA EA200701632A patent/EA011884B1/ru not_active IP Right Cessation
- 2006-03-01 PL PL10188256T patent/PL2281831T3/pl unknown
- 2006-03-01 EP EP20060707446 patent/EP1858917B8/en active Active
- 2006-03-01 AU AU2006222225A patent/AU2006222225B2/en active Active
- 2006-03-01 SI SI200632265T patent/SI2281831T1/en unknown
- 2006-03-01 KR KR1020077022672A patent/KR101357204B1/ko active Protection Beyond IP Right Term
- 2006-03-01 US US11/817,175 patent/US20080171079A1/en not_active Abandoned
- 2006-03-01 DK DK06707446.8T patent/DK1858917T3/da active
- 2006-03-01 PE PE2010000522A patent/PE20100658A1/es not_active Application Discontinuation
- 2006-03-01 BR BRPI0607840-0A patent/BRPI0607840B1/pt active IP Right Grant
-
2007
- 2007-08-22 IL IL185442A patent/IL185442A/en active IP Right Grant
- 2007-08-23 ZA ZA200707144A patent/ZA200707144B/xx unknown
- 2007-08-29 NO NO20074392A patent/NO341841B1/no active Protection Beyond IP Right Term
- 2007-09-24 MA MA30239A patent/MA29714B1/fr unknown
-
2008
- 2008-02-25 HK HK08102085.4A patent/HK1111427A1/xx not_active IP Right Cessation
-
2010
- 2010-05-20 US US12/784,296 patent/US20110045059A1/en not_active Abandoned
-
2011
- 2011-01-07 US US12/986,928 patent/US7939084B1/en active Active
-
2013
- 2013-04-08 JP JP2013080447A patent/JP5840167B2/ja active Active
-
2015
- 2015-02-04 HR HRP20150142TT patent/HRP20150142T1/hr unknown
- 2015-02-20 CY CY20151100179T patent/CY1116108T1/el unknown
-
2017
- 2017-01-03 AR ARP170100008A patent/AR107285A2/es not_active Application Discontinuation
- 2017-01-18 HR HRP20170081TT patent/HRP20170081T1/hr unknown
- 2017-02-10 CY CY20171100188T patent/CY1118629T1/el unknown
-
2018
- 2018-06-19 CY CY20181100636T patent/CY1121211T1/el unknown
- 2018-06-19 CY CY20181100637T patent/CY1120347T1/el unknown
- 2018-06-26 HR HRP20180988TT patent/HRP20180988T1/hr unknown
- 2018-06-26 HR HRP20180989TT patent/HRP20180989T1/hr unknown
- 2018-09-17 CY CY2018025C patent/CY2018025I1/el unknown
- 2018-09-20 LU LU00087C patent/LUC00087I2/fr unknown
- 2018-09-20 NL NL300951C patent/NL300951I2/nl unknown
- 2018-09-20 HU HUS1800038C patent/HUS1800038I1/hu unknown
- 2018-09-20 LT LTPA2018012C patent/LTC2281831I2/lt unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1800038I1 (hu) | Varicella zoster vírus oltóanyag | |
| IL192084A0 (en) | Vaccine | |
| ZA200906115B (en) | Antibodies specific for Varicella Zoster Virus | |
| GB0515135D0 (en) | Vaccine | |
| ZA200709207B (en) | Vaccine | |
| GB0516944D0 (en) | Vaccine | |
| GB0810662D0 (en) | Vaccine | |
| ZA200709210B (en) | Vaccine | |
| GB0709408D0 (en) | Anti-col herpes virus compounds | |
| GB0526412D0 (en) | Vaccine | |
| IL186586A0 (en) | Vaccine | |
| GB0511475D0 (en) | Vaccine | |
| GB0513194D0 (en) | Vaccine | |
| GB0513189D0 (en) | Vaccine | |
| GB0513191D0 (en) | Vaccine | |
| GB0503000D0 (en) | Anti-atheroma vaccine | |
| GB0509010D0 (en) | Vaccine | |
| GB0523445D0 (en) | Vaccine | |
| GB0514021D0 (en) | Vaccine | |
| GB0515242D0 (en) | Vaccine | |
| IL186591A0 (en) | Vaccine |